NASDAQ: SGMT
Sagimet Biosciences Inc Earnings Dates, Reports, Calls

Sagimet Biosciences earnings were -$57.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SGMT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$18.2M, up 12.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SGMT reported annual earnings of -$45.6M, with 63.5% growth.

SGMT earnings history

Current Revenue
$0.0
Current Earnings
-$57.1M
Current Profit Margin
0%

SGMT Return on Equity

Current Company
-35.2%
Current Industry
-60.2%
Current Market
31.5%
SGMT's Return on Equity (-35.2%)... subscribe to Premium to read more.
High Return on Equity Performance

SGMT undefined

Current Company
-34.1%
Current Industry
-2.5%
SGMT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SGMT announces earnings.

SGMT undefined

Current Company
-41.09%
Current Industry
5.8%

SGMT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SGMT-$56.97M-$57.11MN/A-$1.76
VNDA-$47.73M-$44.25MN/A-$0.76
AVIR-$138.18M-$139.49MN/A-$1.65
RNAC-$33.79M-$42.52MN/A-$1.10
ANNX-$163.88M-$167.38MN/A-$1.18

Sagimet Biosciences Earnings Reports & History FAQ

What were Sagimet Biosciences's earnings last quarter?

Sagimet Biosciences (NASDAQ: SGMT) reported Q1 2025 earnings per share (EPS) of -$0.56, up 143.48% year over year. Total SGMT earnings for the quarter were -$18.18 million. In the same quarter last year, Sagimet Biosciences's earnings per share (EPS) was -$0.23.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.

Is Sagimet Biosciences profitable or losing money?

As of the last Sagimet Biosciences earnings report, Sagimet Biosciences is currently losing money. Sagimet Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$57.11 million, a 104.58% increase year over year.

What was SGMT's earnings growth in the past year?

As of Sagimet Biosciences's earnings date in Q2 2025, Sagimet Biosciences's earnings has grown year over year. SGMT earnings in the past year totalled -$57.11 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.